FDA Toughens Stance On OTC, Prescription Pain Relievers

The U.S. Food and Drug Administration on Thursday said it has strengthened warning requirements for nonsteroidal anti-inflammatory drugs, which now must carry more specific labels regarding increased risk of heart attack...

Already a subscriber? Click here to view full article